Abstract
The following position paper summarizes the recommendations for early clinical trials and ongoing basic research in the field of mesenchymal stem cell-induced solid organ graft acceptance--agreed upon on the first meeting of the Mesenchymal Stem Cells In Solid Organ Transplantation (MISOT) study group in late 2008.
MeSH terms
-
Animals
-
Cell- and Tissue-Based Therapy / methods
-
Humans
-
Immunosuppression Therapy / methods*
-
Immunosuppressive Agents / therapeutic use
-
Kidney Transplantation / methods
-
Liver Transplantation / methods*
-
Living Donors
-
Mesenchymal Stem Cell Transplantation / methods*
-
Organ Transplantation / methods*